Mission
THE MISSION OF NDRI IS TO PROVIDE HUMAN BIOSPECIMENS WORLDWIDE TO ADVANCE BIOMEDICAL/BIOSCIENCE RESEARCH AND DEVELOPMENT AND EDUCATION IN THE LIFE SCIENCES.
Public Charity
NATIONAL DISEASE RESEARCH INTERCHANGE
Based in PHILADELPHIA, PA, NATIONAL DISEASE RESEARCH INTERCHANGE operates as a Public Charity. The organization reported $12.8M in revenue, $13.0M in expenses, $7.0M in total assets for fiscal year 2025. Imperigo tracks 15 reported grant relationships connected to this organization totaling approximately $2.4M.
EIN: 232213205
PHILADELPHIA, PA
Medical Research N.E.C.
NTEE: H99
Latest filing: 2025
Total Revenue$12.8M
Total Expenses$13.0M
Total Assets$7.0M
Grant Records15
Funding Total$2.4M
Filing Years2020–2025
Where $100 goes at National Disease Research Interchange
How National Disease Research Interchange divides every $100 it spends, from its own Form 990 filings, averaged across 8 years.
$69
Programs
the work itself
$31
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $69 for programs
$49
Human tissue and resource for research
$14
Research collaborations with foundation and patient advocacy groups (pag): ndri maintains collaborations with a variety of different foundation and patient advocacy groups focused on the advancement of research…
$6
Partner program
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
THERAPEUTICS DISCOVERY RESEARCH
$246,727
RESEARCH - OPG
$19,422
THERAPEUTICS DISCOVERY RESEARCH
$173,763
Program Support
$99,211
THERAPEUTICS DISCOVERY RESEARCH
$346,297
Showing up to 5 of 15 total records — full history available with membership.
Officers & Directors
BOARD MEMBER
Arthur H Rubenstein
DIRECTOR, FULFILLMENT
Dana R Rosales
BOARD MEMBER
David M Albert
BOARD MEMBER
Deanne Taylor
BOARD MEMBER
Howard M Nathan
BOARD MEMBER
Jessica Mulholland
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $12.8M | $13.0M | $7.0M |
| 2024 | $11.3M | $10.6M | $7.1M |
| 2023 | $9.1M | $9.3M | $7.2M |
| 2022 | $7.4M | $8.1M | $6.9M |
| 2020 | $6.5M | $7.3M | $6.4M |
Between 2020 and 2025, reported annual revenue grew from $6.5M to $12.8M (+99%), with total assets most recently reported at $7.0M.
Interactive year-over-year charts and full filing details available with membership.